Surgical ablation of atrial fibrillation: early survival benefit or residual confounding?

Affiliations

Editorial

John J Squiers et al. Eur J Cardiothorac Surg. 2024.

. 2024 Aug 2;66(2):ezae299.

doi: 10.1093/ejcts/ezae299.

¹ Department of Cardiothoracic Surgery, Baylor Scott & White The Heart Hospital - Plano, Plano, TX, USA.

No abstract available

Keywords: Atrial fibrillation; Long-term survival; Provider-preference instrumental variable analysis; Surgical ablation.

Comment on

Surgical ablation, left atrial appendage occlusion or both? Nationwide registry analysis of cardiac surgery patients with underlying atrial fibrillation.
Pasierski M, Batko J, Kuźma Ł, Wańha W, Jasiński M, Widenka K, Deja M, Bartuś K, Hirnle T, Wojakowski W, Lorusso R, Tobota Z, Maruszewski BJ, Suwalski P, Kowalewski M; KROK Investigators. Pasierski M, et al. Eur J Cardiothorac Surg. 2024 Mar 1;65(3):ezae014. doi: 10.1093/ejcts/ezae014. Eur J Cardiothorac Surg. 2024. PMID: 38218721
Reply to Squiers et al.
Pasierski M, Batko J, Suwalski P, Kowalewski M; KROK Investigators. Pasierski M, et al. Eur J Cardiothorac Surg. 2024 Sep 2;66(3):ezae307. doi: 10.1093/ejcts/ezae307. Eur J Cardiothorac Surg. 2024. PMID: 39133166 No abstract available.